Antibiotics Market Size

Report ID: GMI8014
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Antibiotics Market Size

Antibiotics Market size was valued at USD 45.6 billion in 2023 and is estimated to expand at 3.3% CAGR from 2024 to 2032. The global market is experiencing dynamic growth driven by factors such as the growing aging population and the continual development of novel antibiotic formulations.

To get key market trends

Download Free Sample

Also, rising incidence of infectious diseases is driving an increased demand for antibiotics in the market. For instance, a Lancet eClinical medicine report highlighted an elevation in the antibiotic prescriptions for 75% of COVID-19 patients, with sales of crucial antibiotics surging between May 2020 and May 2022. Thus, with rising infections, the demand for potent antimicrobial treatments surged, thereby significantly impacting the market expansion.

Antibiotics are a class of antimicrobial drugs designed to inhibit the growth or destroy bacteria, alleviating bacterial infections. Antibiotics interfere with the vital process essential for bacterial survival, either by disrupting the cell wall synthesis, protein production, or DNA replication. Antibiotics are prescribed to treat bacterial infections ranging from respiratory tract infections, urinary tract infections (UTI) to skin infection as well as sexually transmitted diseases (STDs).

Antibiotics Market Report Attributes
Report Attribute	Details
Base Year:	2023
Antibiotics Market Size in 2023:	USD 45.6 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	3.3%
2024 – 2032 Value Projection:	USD 60.9 Billion
Historical Data for:	2018 – 2023
No. of Pages:	210
Tables, Charts & Figures:	432
Segments covered:	Drug Class, Type, Spectrum, Drug Origin, Route of Administration, Application, Distribution Channel, and Region
Growth Drivers:	Increasing prevalence of infectious disease Rising number of pharmaceutical and biotechnology companies Growing collaborations for antibiotics development Increasing focus on generic medications
Pitfalls & Challenges:	Antibiotic resistance Regulatory obstacles

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global antibiotics industry was valued at USD 45.6 billion in 2023 and is expected to reach USD 60.9 billion by 2032 growing at a CAGR of 3.3% over the analysis period driven by the growing aging population and the continual development of novel antibiotic formulations.

The UTI application is expected to lead the market, projecting the revenue of USD 23.3 billion by 2032, owing to the high incidence of UTIs, particularly among women, that propels the need for antibiotics such as ciprofloxacin and trimethoprim-sulfamethoxazole, crucial in managing these infections.

North America antibiotics market is expected to record strong CAGR throughout 2024 and 2032 due to the high incidence of infectious diseases such as pneumonia and TB.

Abbott Laboratories, AbbVie, Inc., Allergan plc, Basilea Pharmaceutica Ltd., Bayer AG, Bristol Myers Squibb, Cipla Inc., Daiichi Sankyo Company Ltd., Eli Lilly & Co., GlaxoSmithKline plc., Johnson & Johnson, Lupin Inc., Melinta Therapeutics LLC, Merck & Co., Novartis AG, Pfizer Inc., Sandoz, Sanofi, Teva Pharmaceutical Industries Ltd., and Viatris Inc.